Fize-Fontaine, Belgium

Bernard Masereel


Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bernard Masereel: Innovator in Beta-Carboline Derivatives

Introduction

Bernard Masereel is a notable inventor based in Fize-Fontaine, Belgium. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Masereel holds 2 patents that focus on innovative chemical compounds. His latest patents include "Beta carboline derivatives useful in the treatment of proliferative disorders," which provides novel beta-carboline derivatives of specific formulae that are useful in treating proliferative disorders, including cancer. This invention also details the intermediates used in their preparation, the processes for preparing these compounds, and their various uses. Another significant patent is for "Benzene-sulphonamide derivatives and their uses," which further showcases his expertise in developing useful chemical derivatives.

Career Highlights

Throughout his career, Masereel has worked with esteemed institutions such as Facultés Universitaires Notre-Dame de la Paix and Université Libre Bruxelles. His work in these academic environments has allowed him to contribute to research and development in the field of medicinal chemistry.

Collaborations

Masereel has collaborated with notable individuals in his field, including Raphael Frederick and Jeremy Reniers. These collaborations have likely enriched his research and contributed to his innovative outputs.

Conclusion

Bernard Masereel is a distinguished inventor whose work in beta-carboline derivatives and benzene-sulphonamide derivatives has the potential to impact the treatment of various proliferative disorders. His contributions to medicinal chemistry continue to be recognized and valued in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…